Concepedia

Kanjana Perera

KP

22

Publications

1.8K

Citations

17

H-Index

2016

Active since

Affiliations

Population Health Research Institute(Current)

McMaster University

Bayer (Germany)

Bayer (United States)

Hamilton Health Sciences

Kanjana Perera is an author at Population Health Research Institute specializing in medicine, thrombosis, and public health.

ORCID

Top concepts

Publications per year

2016–2023

22

Publications

22

Efficacy and safety of nerinetide for the treatment of acute ischaemic stroke (ESCAPE-NA1): a multicentre, double-blind, randomised controlled trial

Michael D. Hill, Mayank Goyal, Bijoy K. Menon et al. · The Lancet · 2020 · 601 citations · Full text

Recurrent Stroke With Rivaroxaban Compared With Aspirin According to Predictors of Atrial Fibrillation

Jeff S. Healey, David J. Gladstone, Balakumar Swaminathan et al. · JAMA Neurology · 2019 · 201 citations · Full text

Rivaroxaban or aspirin for patent foramen ovale and embolic stroke of undetermined source: a prespecified subgroup analysis from the NAVIGATE ESUS trial

Scott E. Kasner, Balakumar Swaminathan, Pablo M. Lavados et al. · The Lancet Neurology · 2018 · 177 citations · Full text

Embolic strokes of undetermined source: Prevalence and patient features in the ESUS Global Registry

Kanjana Perera, Thomas Vanassche, Jackie Bosch et al. · International Journal of Stroke · 2016 · 137 citations · Full text

Evaluating Rates of Recurrent Ischemic Stroke Among Young Adults With Embolic Stroke of Undetermined Source

Kanjana Perera, Danielle de Sá Boasquevisque, Amanda Taylor et al. · JAMA Neurology · 2022 · 85 citations · Full text

Rows per page

1–5 of 22